F. De Man (Amsterdam, Netherlands), L. Dewachter (Bruxelles, Belgium)
CFTR and risk of pulmonary arterial hypertension: a case report and mendelian randomization study
j. liao (Guangzhou, China), W. He (Guangzhou, China), Y. Chen (Guangzhou, China), Y. Hu (Xianyang, China), Y. Ning (Guangzhou, China), K. Yang (Guangzhou, China), J. Wang (Guangzhou, China)
|   |
CFTR involvement in the pathogenesis of pulmonary arterial hypertension
L. To (Le Plessis-Robinson, France), H. Leribeuz (Le Plessis-Robinson, France), M. Ghigna (LE PLESSIS ROBINSON, France), M. Lambert (Le Plessis-Robinson, France), C. Martin (Le Plessis-Robinson, France), P. Burgel (Le Plessis-Robinson, France), A. Boët (Le Plessis-Robinson, France), F. Becq (Le Plessis-Robinson, France), J. Issard (Le Plessis-Robinson, France), C. Pechoux (Le Plessis-Robinson, France), B. Manoury (Le Plessis-Robinson, France), O. Mercier (Le Plessis-Robinson, France), F. Perros (Le Plessis-Robinson, France), M. Humbert (Le Plessis-Robinson, France), D. Montani (Le Plessis-Robinson, France), F. Antigny (Le Plessis-Robinson, France)
| |
Inflammation biomarkers and risk of pulmonary hypertension: a Mendelian randomization study
Y. Chen (Guangzhou, China), J. Liao (Guangzhou, China), J. Zhang (Guangzhou, China), Y. Chen (Guangzhou, China), J. Wang (Guangzhou, China)
| |
Inhaled liposomal treprostinil (L606) shows extended release in healthy volunteer, as well as prolongs pharmacological effect in hypoxia-induced rat.
P. Kan (Taipei, Taiwan), K. Chen (Taipei, Taiwan), C. Pan (Taipei, Taiwan)
| |
Comparison of Treprostinil Palmitil Inhalation Suspension (TPIS) or Oral Sildenafil (Sild) in a Sugen/Hypoxia Rat Model of PAH.
M. Corboz (Bridgewater, United States of America), S. Gagnon (Sherbrooke, Canada), C. Brodeur (Sherbrooke, Canada), C. Laurent (Sherbrooke, Canada), A. Plaunt (Bridgewater, United States of America), V. Malinin (Bridgewater, United States of America), H. Gauani (Bridgewater, United States of America), D. Chun (Bridgewater, United States of America), Z. Li (Bridgewater, United States of America), D. Cipolla (Bridgewater, United States of America), W. Perkins (Bridgewater, United States of America), R. Chapman (Bridgewater, United States of America)
| |
Additive protective effects of sacubitril/valsartan and bosentan on vascular remodeling in experimental pulmonary hypertension
M. Chaumais (Le Kremlin Bicêtre, France), M. Amar Djessa (Le Kremlin Bicêtre, France), R. Thuillet (Le Kremlin Bicêtre, France), A. Cumont (Le Kremlin Bicêtre, France), L. Tu (Le Kremlin Bicêtre, France), G. Hebert (Le Plessis Robinson, France), P. Gaignard (Le Kremlin Bicêtre, France), A. Huertas (Le Kremlin Bicêtre, France), L. Savale (Le Kremlin Bicêtre, France), M. Humbert (Le Kremlin Bicêtre, France), C. Guignabert (Le Kremlin Bicêtre, France)
| |
Zamicastat decreases cardiac arrhythmias in a rat model of pulmonary arterial hypertension
N. Pires (Coronado (S Mamede e S Romão), Portugal), B. Igreja (Coronado (S Mamede e S Romão), Portugal), L. Magalhaes (Coronado (S Mamede e S Romão), Portugal), M. Bonifacio (Coronado (S Mamede e S Romão), Portugal), E. Chevalier (Coronado (S Mamede e S Romão), Portugal), P. Soares-Da-Silva (Porto, Portugal)
| |
Relationship between Galectin-3 and mineralocorticoid receptor in pulmonary hypertension
C. Tanba (Boston, United States of America), G. Qi (Boston, United States of America), R. Warburton (Boston, United States of America), K. Penumatsa (Boston, United States of America), D. Toksoz (Boston, United States of America), J. Wilson (Boston, United States of America), H. Farber (Boston, United States of America), N. Hill (Boston, United States of America), I. Preston (Boston, United States of America)
| |
Mitophagy plays an important role in hypoxia-induced pulmonary artery smooth muscle cell proliferation
S. Guo (Chengdu, China), Q. Zuo (Chengdu, China), Y. Zhou (Chengdu, China), X. Li (Chengdu, China)
| |
No evidence of desensitization to repeat dosing with treprostinil palmitil inhalation suspension (TPIS) for 32-consecutive days in hypoxia-challenged telemetered rats
R. Chapman (Bridgewater, United States of America), M. Corboz (Bridgewater, United States of America), S. Gagnon (Sherbrooke, Canada), C. Brodeur (Sherbrooke, Canada), A. Plaunt (Bridgewater, United States of America), V. Malinin (Bridgewater, United States of America), H. Gauani (Bridgewater, United States of America), D. Chun (Bridgewater, United States of America), Z. Li (Bridgewater, United States of America), D. Cipolla (Bridgewater, United States of America), W. Perkins (Bridgewater, United States of America)
| |
Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH).
V. Yatsevich (Minsk, Belarus), I. Adzerikho (Minsk, Belarus), ?. Vladimirskaja (Minsk, Belarus), G. Semenkova (Minsk, Belarus)
| |
Basement membrane, a specialized extracellular matrix, shapes endothelial function in IPAH
K. Jandl (Graz, Austria), L. Marsh (Graz, Austria), J. Hoffmann (Graz, Austria), A. Mutgan (Graz, Austria), O. Baum (Berlin, Germany), W. Bloch (Cologne, Germany), K. Sinn (Vienna, Austria), W. Klepetko (Vienna, Austria), A. Heinemann (Graz, Austria), A. Olschewski (Graz, Austria), H. Olschewski (Graz, Austria), G. Kwapiszewska (Graz, Austria)
| |
Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension
G. Murphy (Glasgow (Glasgow), United Kingdom), G. Jayasekera (Glasgow (Glasgow), United Kingdom), J. Mullin (Glasgow (Glasgow), United Kingdom), L. Gallagher (Glasgow (Glasgow), United Kingdom), Y. Dempsie (Glasgow (Glasgow), United Kingdom), D. Welsh (Glasgow (Glasgow), United Kingdom)
| |
Beta 3 adrenoceptor: a potential therapeutic target for pulmonary arterial hypertension
P. Mendes Ferreira (Porto, Portugal), B. Tielemans (Leuven, Belgium), A. Wagenaar (Leuven, Belgium), C. Dessy (Brussels, Belgium), J. Balligand (Brussels, Belgium), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), C. Belge (Leuven, Belgium)
| |
Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH
I. Panselinas (London, United Kingdom), Q. Toe (London, United Kingdom), K. Clementson (London, United Kingdom), M. Ghazaly (London, United Kingdom), S. Wort (London, United Kingdom), G. Quinlan (London, United Kingdom)
| |
Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease.
Y. Joki (Tokyo, Japan), H. Konishi (Tokyo, Japan), K. Takasu (Tokyo, Japan), K. Shimada (Tokyo, Japan)
| |
Extended versus limited stimulation-guided pulmonary artery catheter denervation in normotensive pigs: acute hemodynamic effects
N. Goncharova (Saint-Petersburg, Russian Federation), A. Vakhrushev (Saint-Petersburg, Russian Federation), H. Condori Leandro (Saint-Petersburg, Russian Federation), S. Voronin (Saint-Petersburg, Russian Federation), L. Murashova (Saint-Petersburg, Russian Federation), L. Korobchenko (Saint-Petersburg, Russian Federation), E. Andreeva (Saint-Petersburg, Russian Federation), L. Mitrofanova (Saint-Petersburg, Russian Federation), D. Lebedev (Saint-Petersburg, Russian Federation), O. Moiseeva (Saint-Petersburg, Russian Federation), E. Mikhaylov (Saint-Petersburg, Russian Federation)
| |
Mendelian Randomization Study Showed No Causality between Type 2 Diabetes and Pulmonary Hypertension
J. Zhang (Guangzhou, China), J. Liao (Guangzhou, China), Y. Chen (Guangzhou, China), Y. Chen (Guangzhou, China), J. Wang (Guangzhou, China)
| |
Role of IL-11 system in Pulmonay Hypertension
I. Roger (Valencia, Spain), J. Milara (Valencia, Spain), C. Estornut (Valencia, Spain), A. Bayarri (Valencia, Spain), A. Garcia (Valencia, Spain), J. Cortijo (Valencia, Spain)
| |
No indication of insulin resistance in idiopathic PAH with preserved physical activity
B. Nagy (Graz, Austria), G. Kovacs (Graz, Austria), A. Tornyos (Graz, Austria), E. Svehlikova (Graz, Austria), V. Foris (Graz, Austria), C. Nagaraj (Graz, Austria), G. Kwapiszewska (Graz, Austria), . R. Pieber (Graz, Austria), A. Olschewski (Graz, Austria), H. Olschewski (Graz, Austria)
| |